|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 48/00 | (2006.01) |
| C12N 15/861 | (2006.01) |
| (11) | Number of the document | 3191139 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15825383.1 |
| Date of filing the European patent application | 2015-07-17 | |
| (97) | Date of publication of the European application | 2017-07-19 |
| (45) | Date of publication and mention of the grant of the patent | 2020-10-07 |
| (46) | Date of publication of the claims translation | 2021-01-25 |
| (86) | Number | PCT/US2015/040866 |
| Date | 2015-07-17 |
| (87) | Number | WO 2016/014353 |
| Date | 2016-01-28 |
| (30) | Number | Date | Country code |
| 201462028638 P | 2014-07-24 | US |
| (72) |
SANDBERG, Michael A., US
PAWLYK, Basil, US
LI, Tiansen, US
SHU, Xinhua, GB
WRIGHT, Alan Finlay, GB
ALI, Robin, US
|
| (73) |
Massachusetts Eye & Ear Infirmary,
243 Charles Street, Boston, MA 02114,
US
UCL Business Ltd, The Network Building 97 Tottenham Court Road, London W1T 4TP, GB The Government of the United States of America as represented by the Secretary, Department of Health and Human Service, The Office of Technology Transfer National Institutes of Health 6011 Executive Boulevard Suite 325, MSC 7660, Bethesda, MD 20892-7660, US |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Pigmentiniam retinitui skirta RPGR genų terapija |
| RPGR GENE THERAPY FOR RETINITIS PIGMENTOSA |
| Payment date | Validity (years) | Amount | |
| 2025-07-01 | 11 | 289.00 EUR |
| 2026-07-17 |